• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从唾液样本中测定异烟肼半衰期。

Determination of isoniazid half-life from salivary samples.

作者信息

Suryawati S, Santoso B

出版信息

Int J Clin Pharmacol Ther Toxicol. 1986 Jan;24(1):18-22.

PMID:3957485
Abstract

Measurements of isoniazid (INH) half-lives from salivary samples were conducted in 8 healthy volunteers. The study showed a significant positive correlation between salivary and serum INH concentrations (rs = 0.92, n = 50) with the mean saliva/serum concentration ratio of 0.81 (+/- s. e. m. 0.05). The correlation in INH concentration between salivary and serum samples obtained during the elimination phase (rs = 0.92, n = 50) was greater than that obtained during the absorption phase (rs = 0.71, n = 18). The measurements of INH half-lives from salivary samples were very close to those from serum (rs = 0.95, n = 8), and no misclassification into either phenotype was made by using salivary INH half-life for acetylator phenotyping, compared to that by using serum samples. It was concluded, therefore, that INH half-life measurement from saliva could be used as a reliable and convenient method for acetylator phenotyping. However, the calculation of absorption kinetic parameter, of clearance and of the volume of distribution of INH by using salivary samples could not be justified.

摘要

对8名健康志愿者的唾液样本进行了异烟肼(INH)半衰期的测量。研究表明,唾液和血清中INH浓度之间存在显著正相关(rs = 0.92,n = 50),唾液/血清浓度平均比值为0.81(±标准误0.05)。消除期获得的唾液和血清样本中INH浓度的相关性(rs = 0.92,n = 50)大于吸收期获得的相关性(rs = 0.71,n = 18)。唾液样本中INH半衰期的测量值与血清测量值非常接近(rs = 0.95,n = 8),与使用血清样本相比,使用唾液INH半衰期进行乙酰化酶表型分析时,没有出现任何表型误分类情况。因此得出结论,唾液中INH半衰期的测量可作为一种可靠且便捷的乙酰化酶表型分析方法。然而,利用唾液样本计算INH的吸收动力学参数、清除率和分布容积是不合理的。

相似文献

1
Determination of isoniazid half-life from salivary samples.从唾液样本中测定异烟肼半衰期。
Int J Clin Pharmacol Ther Toxicol. 1986 Jan;24(1):18-22.
2
Pharmacokinetics of metronidazole in saliva.甲硝唑在唾液中的药代动力学
Int J Clin Pharmacol Ther Toxicol. 1991 Dec;29(12):474-8.
3
Isoniazid acetylation phenotyping in Saudi Arabs.沙特阿拉伯人的异烟肼乙酰化表型分析
J Clin Pharm Ther. 2004 Oct;29(5):443-7. doi: 10.1111/j.1365-2710.2004.00588.x.
4
Sulfadimidine and isoniazid loading in man and laboratory rats. Pharmacokinetic and pharmacogenetic results on drug acetylation.人及实验大鼠体内磺胺二甲嘧啶和异烟肼的负荷量。药物乙酰化的药代动力学和药物遗传学结果。
Arzneimittelforschung. 1980;30(9):1574-9.
5
Estimation of pharmacokinetic parameters of digoxin from serum, saliva and urine.从血清、唾液和尿液中估算地高辛的药代动力学参数。
Int J Clin Pharmacol Biopharm. 1978 Sep;16(9):420-3.
6
A single sample saliva test to determine acetylator phenotype.一种用于确定乙酰化酶表型的单样本唾液检测。
Br J Clin Pharmacol. 1996 Nov;42(5):635-7. doi: 10.1111/j.1365-2125.1996.tb00121.x.
7
Isoniazid disposition, comparison of isoniazid phenotyping methods in and acetylator distribution of Japanese patients with idiopathic systemic lupus erythematosus and control subjects.异烟肼代谢、日本特发性系统性红斑狼疮患者与对照受试者的异烟肼表型分析方法比较及乙酰化酶分布
Br J Clin Pharmacol. 1982 Mar;13(3):361-74. doi: 10.1111/j.1365-2125.1982.tb01387.x.
8
The pharmacokinetics of dapsone and acetylated dapsone in serum and saliva.氨苯砜及乙酰化氨苯砜在血清和唾液中的药代动力学。
Int J Clin Pharmacol Biopharm. 1979 Apr;17(4):159-63.
9
Acetylator phenotyping: a comparison of the isoniazid and dapsone tests.乙酰化酶表型分析:异烟肼和氨苯砜试验的比较
Eur J Clin Pharmacol. 1981;20(3):233-4. doi: 10.1007/BF00544604.
10
A simple method for determining acetylator phenotype using isoniazid.一种使用异烟肼测定乙酰化酶表型的简单方法。
Br J Clin Pharmacol. 1986 Sep;22(3):343-5. doi: 10.1111/j.1365-2125.1986.tb02897.x.

引用本文的文献

1
Systematic Review of Salivary Versus Blood Concentrations of Antituberculosis Drugs and Their Potential for Salivary Therapeutic Drug Monitoring.抗结核药物唾液浓度与血液浓度及其唾液治疗药物监测潜力的系统评价。
Ther Drug Monit. 2018 Feb;40(1):17-37. doi: 10.1097/FTD.0000000000000462.